🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
A phase 3 study to evaluate the efficacy and safety of SY-3505 vs. crizotin...
Status
Not Yet Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-05-01
Trial ID
NCT06254599
Treatments Being Tested
PF-02341066 may work in cancer by blocking the cell growth, migration and i...
Status
Completed
Location
University of California, Irvine Medical Center
Start Date
2006-04-19
Trial ID
NCT00585195
Treatments Being Tested
This phase II MATCH treatment trial tests how well crizotinib works in trea...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2016-07-29
Trial ID
NCT06357975
Treatments Being Tested
This is a phase 2 study of a drug called crizotinib in people with metastat...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2019-12-03
Trial ID
NCT04084717
Treatments Being Tested
The purpose of the study is to investigate the effect and side effects of p...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2022-09-27
Trial ID
NCT05725200
Brigatinib is a medicine that binds to the surface of tumor cells in some c...
Status
Completed
Location
The Oncology Institute of Hope and Innovation
Start Date
2019-04-19
Trial ID
NCT03596866
Treatments Being Tested
Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), was approved ...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2015-09
Trial ID
NCT02708667
This randomized, multicenter, Phase III, open-label study will evaluate the...
Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2021-12-31
Trial ID
NCT06569420
Treatments Being Tested